Deep learning models can help assess lung cancer diagnoses.

Published Date: 02 Mar 2023

A deep learning model called Sybil can predict future lung cancer risk based on a low-dose chest CT scan and identify people who are likely to benefit from regular treatment.

Read Full News

Latest News

An Oral Ketamine Drug for Depression — Minus the Trip?

A novel oral ketamine drug shows a signal for reducing depressive symptoms with minimal dissociative effects.

Europe’s AI Reality: Practice Outpaces Policy and Reviews

Clinicians and patients are already relying on AI, while hospitals are still building the oversight to keep up.

Fast Symptom Relief in Ulcerative Colitis: Which Rx Wins?

Upadacitinib and infliximab offer rapid relief from symptoms in biologic-naive patients with moderate-to-severe ulcerative colitis.

Info on Risk for Prostate Cancer Spurs Decision-Making

Men who receive personalized estimates of the likelihood of raised prostate-specific antigen levels are more likely to decide to get screening than those who receive general information on pros and cons.

Cognitive Benefit of Healthy Living Confirmed: LatAm-FINGERS

A culturally tailored lifestyle program improves cognition significantly more than standard health advice among older adults at risk for dementia across Latin America.

Rimegepant Effective in Treatment-Resistant Migraine

Rimegepant is safe and effective in patients with migraine not responding to multiple prior preventive therapies, a real-world study shows.

Todays Updates

Body Clock Genes Tied to Prostate Radiotherapy Toxicity

Could timing prostate cancer radiotherapy according to patients’ circadian rhythm genes reduce the risk for late side effects?

Gedatolisib Combo Approved for Advanced Breast Cancer

Progression-free survival with the multitarget PAM inhibitor approaches 10 months after anti-CDK4/6 and aromatase inhibitor failure.

MGRS Relapse-Free Survival Better With Maintenance Therapy

Researchers retrospectively analyzed outcomes for 50 patients with biopsy-proven monoclonal gammopathy of renal significance for a median follow-up of 6.15 years.

Lung Transplant for Lung Cancer: Promising, in Rare Cases

In a small single-center study, 1-year survival is 100% among carefully selected patients who undergo bilateral lung transplantation for stage IV disease confined to the lungs.

Todays Updates

Body Clock Genes Tied to Prostate Radiotherapy Toxicity

Could timing prostate cancer radiotherapy according to patients’ circadian rhythm genes reduce the risk for late side effects?

Gedatolisib Combo Approved for Advanced Breast Cancer

Progression-free survival with the multitarget PAM inhibitor approaches 10 months after anti-CDK4/6 and aromatase inhibitor failure.

MGRS Relapse-Free Survival Better With Maintenance Therapy

Researchers retrospectively analyzed outcomes for 50 patients with biopsy-proven monoclonal gammopathy of renal significance for a median follow-up of 6.15 years.

Lung Transplant for Lung Cancer: Promising, in Rare Cases

In a small single-center study, 1-year survival is 100% among carefully selected patients who undergo bilateral lung transplantation for stage IV disease confined to the lungs.

Latest News

A novel oral ketamine drug shows a signal for reducing depressive symptoms with minimal dissociative effects.

Clinicians and patients are already relying on AI, while hospitals are still building the oversight to keep up.

Upadacitinib and infliximab offer rapid relief from symptoms in biologic-naive patients with moderate-to-severe ulcerative colitis.

Men who receive personalized estimates of the likelihood of raised prostate-specific antigen levels are more likely to decide to get screening than those who receive general information on pros and cons.

A culturally tailored lifestyle program improves cognition significantly more than standard health advice among older adults at risk for dementia across Latin America.

Rimegepant is safe and effective in patients with migraine not responding to multiple prior preventive therapies, a real-world study shows.

News All Time

Most Cardiology Is Geriatric Cardiology: Expert Tips

Geriatric cardiologists John Dodson and Ashok Krishnaswami discuss key tips and strategies for managing older adult cardiac patients.

Debunking Diet and Cancer Myths in the Clinic

Dr Shikha Jain separates fact from fiction on sugar, toxic supplements, and the clinical power of exercise in oncology.

Breast Implants: Is Routine 10-Year Exchange Needed?

The widely cited 10-year timeline for breast implant replacement may reflect tradition more than evidence, with experts instead emphasizing long-term surveillance.

Prostate Drug Shows Mixed Results for Lower Urinary Symptoms

Men had nearly three fewer daily symptoms with tamsulosin than on placebo.

Mental Health Bidirectionally Linked to Cognition in Pain

Mental health conditions are linked to a 78% higher risk for cognitive impairment (CI) in older adults with chronic pain, while CI is tied to higher MHC risk, research shows.

When Medical Mistrust, Wellness, and Politics Align

Decades of systemic failure have left patients feeling more heard outside the clinic than in it. Here’s what doctors can do.

Weight Loss While Taking Antipsychotics: Which Rx Works Best

Researchers analyzed data on 39 weight-loss drugs taken by patients on antipsychotics for schizophrenia. Which one offered the best results?

Treat-to-Target Strategy Is Feasible in Elderly-Onset RA

A treat-to-target approach appears feasible in patients with elderly-onset rheumatoid arthritis, with similar disease control and safety profiles as those with younger-onset disease, a study finds.

High Eye Pressure? Vitamin B3 May Shield Against Glaucoma

Supplementation with vitamin B3 is associated with a 66% lower risk of developing glaucoma in people with high eye pressure, a real-world study shows.

Nursing Faculty Shortage Is Limiting the RN Pipeline

There are too few nursing faculty to educate the next generation of nurses.

Most Child Flu Deaths Occur in Those Unvaccinated

Children and adolescents who die from influenza-related illness are less likely to have received the vaccine for the current season, per an analysis of pediatric deaths over eight seasons in the US.

Game Changers: How Lorlatinib Shifts the Landscape

Dr Mark Kris breaks down why lorlatinib is a true game changer in ALK+ NSCLC, offering unprecedented 5-year PFS data alongside essential strategies to manage its unique toxicities.

FDA Psychiatry Roundup: June 2026

A monthly overview of FDA actions for psychiatric treatments and therapies.

CADe Succeeds in Real-World Colonoscopy QI Study

AI-based computer-aided detection devices during colonoscopy was associated with higher adenoma detection rates than usual care, a pragmatic, quality improvement trial shows.

Adjunctive Trauma Therapy May Help Improve Psychosis Care

Trauma-focused therapy is associated with reduced PTSD symptom severity and increased remission in patients with co-occurring psychosis, a new randomized trial shows.

APOL1 Status May Refine Long-Term Kidney Donor Risk

High-risk APOL1 genotypes are associated with greater long-term kidney dysfunction among Black living donors, suggesting a potential role for genetic screening during donor evaluation.

Recommended News For You

Scientists identify dual protein targets to weaken pancreatic cancer defenses

EGFR Inhibitors for Lung Cancer Tied to Increased Keratitis Risk.

Report reveals lung cancer is the leading cause of cancer deaths in Florida

For fit patients with CLL, frontline venetoclax-ibrutinib improves survival.

Benzene in Cold Med; Male Cancer Death to Rise 93%; Mail-Order Drugs Compromised?

Promising for Monitoring and Diagnosis of AD is the finger-prick test.

Researchers publish action plan to address appendiceal cancer enigmas

Recommended Articles For You

Exploring the Mysteries of MGUS: Uncovering the Causes and Treatments 

Empowering Lung Cancer Diagnosis Through the Synergy of Advanced Technologies and Artificial Intelligence 

The Predictive Power of Theranostics in Palliative Neuroendocrine Tumor Management 

Colorectal Cancer Uncovered: CME, Case Studies, and Clinical Strategies 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

J. Craig Venter, Who Won the Race to Sequence the Human Genome, Dies at 79

2.

Antitumor cell activity in glioblastoma is controlled by blocking the triggering receptor expressed on myeloid cells 2.

3.

Black and Hispanic children with high-risk neuroblastoma have worse outcomes despite standardized treatment

4.

The self-sacrificing nature of breast cancer cells has been identified as a possible reason for relapse.

5.

Too Many Kids With Sickle Cell Disease Aren't Getting Appropriate Preventive Care

1.

Metabolic Symbiosis Within the Tumor Niche: Mechanisms, Clinical Implications, and Therapeutic Opportunities

2.

The Mysterious World of Petechiae: Exploring Causes and Treatments

3.

Uncovering the Hidden Picture: Using Ultrasound to Diagnose Breast Cancer

4.

Don't Ignore Your Vision Loss: What You Need to Know About Amaurosis Fugax 

5.

Exploring The Science Of Hematopoietic Stem Cell Transplantation: What You Need To Know

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V

2.

Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

3.

A Panel Discussion on Clinical Trial End Point for Tumor With PPS > 12 months

4.

Navigating the Complexities of Ph Negative ALL - Part VII

5.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot